Phibilin

General Information


DRACP ID  DRACP04391

Peptide Name   Phibilin

Sequence  RGDILKRWAGHFSKLL

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C88H141N27O20

Absent amino acids  CEMNPQTVY

Common amino acids  L

Mass  216500

Pl  11.65

Basic residues  5

Acidic residues  1

Hydrophobic residues  7

Net charge  4

Boman Index  -2904

Hydrophobicity  -34.38

Aliphatic Index  103.75

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  366.67

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 35633688

Title  In vitro and in vivo Activity of Phibilin Against Candida albicans

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19283

DRACP is developed by Dr.Zheng's team.